TRCT
SANA icon

Tower Research Capital (TRC)’s Sana Biotechnology SANA Stock Holding History

Tower Research Capital (TRC)’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Sell
4,992
-39,069
-89% -$126K ﹤0.01% 3673
2026
Q1 		$127K Buy
44,061
+42,477
+2,682% +$167K ﹤0.01% 1993
2025
Q4 		$6.45K Sell
1,584
-6,575
-81% -$29.4K ﹤0.01% 4064
2025
Q3 		$29K Sell
8,159
-21,488
-72% -$77.7K ﹤0.01% 2969
2025
Q2 		$80.9K Sell
29,647
-8,639
-23% -$17.8K ﹤0.01% 2556
2025
Q1 		$64.3K Buy
38,286
+23,150
+153% +$64.7K ﹤0.01% 2044
2024
Q4 		$24.7K Buy
15,136
+10,548
+230% +$31.5K ﹤0.01% 3037
2024
Q3 		$19.1K Sell
4,588
-14,001
-75% -$73.6K ﹤0.01% 3263
2024
Q2 		$101K Buy
18,589
+17,367
+1,421% +$138K ﹤0.01% 2570
2024
Q1 		$12.2K Sell
1,222
-32,885
-96% -$246K ﹤0.01% 3500
2023
Q4 		$139K Buy
34,107
+30,796
+930% +$113K ﹤0.01% 2375
2023
Q3 		$12.8K Sell
3,311
-8,732
-73% -$46.9K ﹤0.01% 3857
2023
Q2 		$71.8K Buy
12,043
+7,228
+150% +$41.7K ﹤0.01% 2287
2023
Q1 		$16K Buy
4,815
+3,337
+226% +$13.3K ﹤0.01% 3732
2022
Q4 		$5K Sell
1,478
-26,170
-95% -$128K ﹤0.01% 4904
2022
Q3 		$166K Buy
27,648
+13,284
+92% +$95.9K ﹤0.01% 2105
2022
Q2 		$92K Buy
14,364
+6,594
+85% +$42K ﹤0.01% 2362
2022
Q1 		$64K Buy
7,770
+376
+5% +$3.04K ﹤0.01% 2540
2021
Q4 		$115K Buy
7,394
+2,319
+46% +$44.7K ﹤0.01% 2150
2021
Q3 		$114K Buy
5,075
+1,609
+46% +$33.8K ﹤0.01% 2287
2021
Q2 		$68K Buy
3,466
+3,066
+767% +$69.5K ﹤0.01% 2761
2021
Q1 		$13K Buy
+400
New +$13K ﹤0.01% 4220

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Tower Research Capital (TRC)'s SANA Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Sana Biotechnology (SANA) stake by 89% in Q2 2026, selling an estimated $126K and leaving 4,992 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3673.

Tower Research Capital (TRC) first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $166K in Q3 2022. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Tower Research Capital (TRC) held 4,992 shares of Sana Biotechnology worth $17.4K as of Q2 2026.
  • Tower Research Capital (TRC) sold 39,069 Sana Biotechnology shares in Q2 2026, an estimated $126K.
  • Sana Biotechnology made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3673 holding.
  • Tower Research Capital (TRC) first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s Sana Biotechnology position peaked at $166K in Q3 2022.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.